| abstract |
The present invention relates to the use of a compound of formula (I) and a pharmaceutically acceptable acid addition salt thereof for the manufacture of a medicament for the treatment of 5-HT 5A receptor related diseases:n n n Formula In n n n n n n n Wheren n n R 1 is hydrogen, lower alkyl or halogen;n n n R 2 is hydrogen, lower alkyl, lower alkoxy, halogen, lower alkyl substituted by halogen or cyano;n n n Aryl is phenyl, naphthyl or indan-5-yl;n n n n is 1 or 2. |